Posted on November 16, 2019 by Novartis eyes $1B sales with FDA nod for targeted sickle cell disease drug Adakveo – FiercePharma Novartis eyes $1B sales with FDA nod for targeted sickle cell disease drug Adakveo FiercePharmaView full coverage on Google News
